ArticleJournal of translational medicine2023

Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer.

Alice Mogenet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.